Longterm Outcomes and Treatment After Myocardial Infarction in Patients with Rheumatoid Arthritis

REFERENCES

1. 1.↵
   1. Maradit-Kremers H,
   2. Crowson C,
   3. Nicola P,
   4. Baliman K,
   5. Roger V,
   6. Jacobsen S,
   7. et al.

   Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: A population-based cohort study. Arthritis Rheum 2005;52:402–11.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Van Doornum S,
   2. McGoll G,
   3. Wicks I

   . Accelerated atherosclerosis: An extraarticular feature of rheumatoid arthritis? Arthritis Rheum 2002;46:862–73.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Kaplan M,
   2. McCune W

   . New evidence for vascular disease in patients with early rheumatoid arthritis. Lancet 2003;361:1068–9.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Wolfe F,
   2. Freundlich B,
   3. Straus W

   . Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. J Rheumatol 2003;30:36–40.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Wallberg-Jonsson S,
   2. Ohman M,
   3. Dahlqvist S

   . Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J Rheumatol 1997;24:445–51.

   OpenUrlPubMed
6. 6.↵
   1. Wallberg-Jonsson S,
   2. Johansson H,
   3. Ohman M,
   4. Rantapaa-Dahlqvist S

   . Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis: A retrospective cohort study from disease onset. J Rheumatol 1999;26:2562–71.

   OpenUrlPubMed
7. 7.↵
   1. Solomon D,
   2. Karlson E,
   3. Rimm E,
   4. Cannuscio C,
   5. Mandl L,
   6. Manson J,
   7. et al.

   Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003;107:1303–7.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Libby P,
   2. Ridker P,
   3. Maseri A

   . Inflammation and atherosclerosis. Circulation 2002;105:1135–43.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Del Rincon I,
   2. Williams K,
   3. Stern M,
   4. Freeman G,
   5. Escalante A

   . High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001;44:2737–45.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Gonzalez-Gay M,
    2. Gonzalez-Juanatey C,
    3. Pineiro A,
    4. Garcia-Porrua C,
    5. Testa A,
    6. Llorca J

    . High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis. J Rheumatol 2005;32:1219–23.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Sattar N,
    2. McCarey D,
    3. Capell H,
    4. McInnes I

    . Explaining how “high-grade” systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 2003;108:2957–63.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. Van Doornum S,
    2. Brand C,
    3. King B,
    4. Sundararajan V

    . Increased case fatality rates following a first acute cardiovascular event in patients with rheumatoid arthritis. Arthritis Rheum 2006;54:2061–8.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Van Doornum S,
    2. Brand C,
    3. Sundararajan V,
    4. Ajani AE,
    5. Wicks IP

    . Rheumatoid arthritis patients receive less frequent acute reperfusion and secondary prevention therapy after myocardial infarction compared with the general population. Arthritis Res Ther 2010;12:R183.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Sodergren A,
    2. Stegmayr B,
    3. Lundberg V,
    4. Ohman M,
    5. Wallberg-Jonsson S

    . Increased incidence of and impaired prognosis after acute myocardial infarction among patients with seropositive rheumatoid arthritis. Ann Rheum Dis 2007;66:263–6.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. Douglas K,
    2. Pace A,
    3. Treharne G,
    4. Saratzis A,
    5. Nightingale P,
    6. Erb N,
    7. et al.

    Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome. Ann Rheum Dis 2006;65:348–53.

    OpenUrlAbstract/FREE Full Text
16. 16.↵
    1. Melton L

    . History of the Rochester Epidemiology Project. Mayo Clin Proc 1996;71:266–74.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Gillum R,
    2. Fortmann S,
    3. Prineas R,
    4. Kottke T

    . International diagnostic criteria for acute myocardial infarction and acute stroke. Am Heart J 1984;108:150–8.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Jabre P,
    2. Jouven X,
    3. Adnet F,
    4. Thabut G,
    5. Bielinski S,
    6. Weston S,
    7. et al.

    Atrial fibrillation and death after myocardial infarction: A community study. Circulation 2011;123:2094–100.

    OpenUrlAbstract/FREE Full Text
19. 19.↵
    1. Prineas R,
    2. Crow R,
    3. Blackburn H

    . Minnesota code manual of electrocardiographic findings: Standards and procedures for measurement and classification. Littleton, MA: Wright-PSG; 1982.
20. 20.↵
    1. Arnett F,
    2. Edworthy SM,
    3. Bloch DA,
    4. McShane D,
    5. Fries J,
    6. Cooper N,
    7. et al.

    The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–24.

    OpenUrlCrossRefPubMed
21. 21.↵
    1. Ho K,
    2. Pinsky J,
    3. Kannel W,
    4. Levy D

    . The epidemiology of heart failure: The Framingham Study. J Am Coll Cardiol 1993;22:6A–13A.

    OpenUrlCrossRefPubMed
22. 22.↵
    1. Thom T,
    2. Haase N,
    3. Rosamond W,
    4. Howard VJ,
    5. Rumsfeld J,
    6. Manolio T,
    7. et al.

    Heart disease and stroke statistics — 2006 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006;113:e85–e151.

    OpenUrlFREE Full Text
23. 23.↵
    1. Turesson C,
    2. O’Fallon W,
    3. Crowson C,
    4. Gabriel S,
    5. Matteson E

    . Extra-articular disease manifestations in rheumatoid arthritis: Incidence trends and risk factors over 46 years. Ann Rheum Dis 2003;62:236–41.

    OpenUrlAbstract/FREE Full Text
24. 24.↵
    1. Grambsch P,
    2. Therneau T

    . Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994;81:515–26.

    OpenUrlAbstract/FREE Full Text
25. 25.↵
    1. Francis ML,
    2. Varghese JJ,
    3. Mathew JM,
    4. Koneru S,
    5. Scaife SL,
    6. Zahnd WE

    . Outcomes in patients with rheumatoid arthritis and myocardial infarction. Am J Med 2010;123:922–8.

    OpenUrlCrossRefPubMed
26. 26.↵
    1. Beller GA

    . President’s page: Geographic variations in delivery of cardiovascular care: An issue of great importance to cardiovascular specialists. J Am Coll Cardiol 2000;36:652–5.

    OpenUrlCrossRefPubMed
27. 27.↵
    1. Anderson HV,
    2. Shaw RE,
    3. Brindis RG,
    4. Hewitt K,
    5. Krone RJ,
    6. Block PC,
    7. et al.

    A contemporary overview of percutaneous coronary interventions: The American College of Cardiology–National Cardiovascular Data Registry (ACC–NCDR). J Am Coll Cardiol 2002;39:1096–103.

    OpenUrlCrossRefPubMed
28. 28.↵
    1. The Center for the Evaluative Clinical Sciences, Dartmouth Medical School; The Center for Outcomes Research and Evaluation, Maine Medical Center

    . The Dartmouth atlas of cardiovascular health care. Chicago: AHA Press; 1999.
29. 29.↵
    1. Krishnan E,
    2. Lingala VB,
    3. Sing G

    . Declines in mortality from acute myocardial infarction in successive incidence and birth cohorts of patients with rheumatoid arthritis. Circulation 2004;110:1774–9.

    OpenUrlAbstract/FREE Full Text
30. 30.↵
    1. Varghese JJ,
    2. Sushma K,
    3. Scaife SL,
    4. Zahnd WE,
    5. Francis ML

    . Mortality after coronary artery revascularization of patients with rheumatoid arthritis. J Thoracic Cardiovas Surg 2010;140:91–6.

    OpenUrlCrossRefPubMed
31. 31.↵
    1. Gabriel S

    . Cardiovascular morbidity and mortality in rheumatoid arthritis. Am J Med 2008;121 Suppl:S9–S14.

    OpenUrlCrossRefPubMed
32. 32.↵
    1. Maradit-Kremers H,
    2. Nicola P,
    3. Crowson C,
    4. Ballman K,
    5. Gabriel S

    . Cardiovascular death in rheumatoid arthritis: A population-based study. Arthritis Rheum 2005;52:722–32.

    OpenUrlCrossRefPubMed
33. 33.↵
    1. Goodson N,
    2. Symmons D,
    3. Scott D,
    4. Bunn D,
    5. Lunt M,
    6. Silman A

    . Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: A ten-year followup study of a primary care-based inception cohort. Arthritis Rheum 2005;52:2293–9.

    OpenUrlCrossRefPubMed
34. 34.↵
    1. St. Sauver J,
    2. Grossardt B,
    3. Leibson C,
    4. Yawn B,
    5. Melton LR,
    6. Rocca W

    . Generalizability of epidemiological findings and public health decisions: An illustration from the Rochester Epidemiology Project. Mayo Clin Proc 2012;87:151–60.

    OpenUrlCrossRefPubMed